Placebo liquid (not containing the active substance
Sponsors
Incyte Corp.
Conditions
Metastatic nonsquamous or squamous non-small cell lung cancerSquamous Carcinoma of the Anal Canal
Phase 3
INCMGA 0012-303: A Phase 3 Global, Multicenter, Double-Blind Randomized Study of Carboplatin-Paclitaxel With INCMGA00012 or Placebo in Participants With Inoperable Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Anal Canal Not Previously Treated With Systemic Chemotherapy (POD1UM-303/InterAACT 2)
CompletedCTIS2024-512331-72-00
Start: 2020-12-22End: 2025-09-26Target: 201Updated: 2025-07-16
A Randomized, Double Blind, Phase 3 Study of Platinum-Based Chemotherapy With or Without INCMGA00012 in First-Line Metastatic Squamous and Nonsquamous Non–Small Cell Lung Cancer (POD1UM-304)
Active, not recruitingCTIS2022-501987-16-00
Start: 2020-10-02Target: 14Updated: 2025-08-05